Shnayder, N.A.; Petrova, M.M.; Shesternya, P.A.; Savinova, A.V.; Bochanova, E.N.; Zimnitskaya, O.V.; Pozhilenkova, E.A.; Nasyrova, R.F.
Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions. Biomedicines 2021, 9, 451.
https://doi.org/10.3390/biomedicines9050451
AMA Style
Shnayder NA, Petrova MM, Shesternya PA, Savinova AV, Bochanova EN, Zimnitskaya OV, Pozhilenkova EA, Nasyrova RF.
Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions. Biomedicines. 2021; 9(5):451.
https://doi.org/10.3390/biomedicines9050451
Chicago/Turabian Style
Shnayder, Natalia A., Marina M. Petrova, Pavel A. Shesternya, Alina V. Savinova, Elena N. Bochanova, Olga V. Zimnitskaya, Elena A. Pozhilenkova, and Regina F. Nasyrova.
2021. "Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions" Biomedicines 9, no. 5: 451.
https://doi.org/10.3390/biomedicines9050451
APA Style
Shnayder, N. A., Petrova, M. M., Shesternya, P. A., Savinova, A. V., Bochanova, E. N., Zimnitskaya, O. V., Pozhilenkova, E. A., & Nasyrova, R. F.
(2021). Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions. Biomedicines, 9(5), 451.
https://doi.org/10.3390/biomedicines9050451
